Delivery Order SPE2DB20D3303-SPE2DB25FZ7N2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML insulin in 3ml quantities. This firm fixed price, competitively awarded contract was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single transaction executed...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,403.24 for Lantus SoloStar 100 Unit/mL 3mL insulin on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,738.76 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin, with an ultimate completion date of August 28, 2025. This non-competitive delivery order was issued under a firm fixed price arrangement, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a routine pharmaceutical procurement action...
- The Defense Logistics Agency awarded a $1,968.89 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Lantus SoloStar 100 Unit/ML insulin in 3 mL quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 5, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,807.03 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 unit/mL 3 mL insulin, with an ultimate completion date of August 6, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and represents a single transaction under the company's larger contract vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency has awarded a delivery order valued at $1,965.00 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML insulin, with a completion date of August 21, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania, where the company is headquartered. The contract falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,500.72 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 unit/mL insulin in 3 mL formulations, with an ultimate completion date of September 5, 2025. This competitive award utilizes firm fixed-price pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $2,366.77 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL formulations. This non-competitive delivery order, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a firm fixed-price transaction executed under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin on August 5, 2025, with completion scheduled for August 6, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a $1,534.20 delivery order to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. The contract, executed on August 6, 2025, with an ultimate completion date of August 7, 2025, utilizes firm fixed pricing under a non-set-aside competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FZ7N2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,450.76 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. This non-competitive delivery order, issued on May 8, 2025, with an ultimate completion date of May 9, 2025, represents a firm fixed price transaction for pharmaceutical supply. The award was fulfilled by AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and critical federal medical procurement vendor. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999.99 billion global pharmaceutical support vehicle extending through December 2026. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. The company's federal contracting demonstrates consistent capability to fulfill competitive procurement requirements across multiple therapeutic domains in support of the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 5/8/25 |